Duloxetine hydrochloride

This classification denotes an antidepressant agent with the molecular formula C18H19NOS.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9044SC542W, chemically known as 5-chloro-1-(1-(3-(2-oxo-2,3-dihydro-1h-benzimidazol-1-yl)propyl)-4-piperidinyl)-1,3-dihydro-2h-benzimidazol-2-one but more generally known as duloxetine hydrochloride, which bears US NIH Compound Identifier 3151. European Medicines Agency schedules Duloxetine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20026. Most nations, for tariff and trade purposes, schedule duloxetine hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, DULOXETINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Duloxetine hydrochloride bears US NLM identifiers UMLS ID C1505021 and NCI Concept Code C65496. SMILES: CNCC[C@@H](C1CCCS1)OC2CCCC3C2CCCC3.CL.